Wendy Champness

883 citations
13 papers · 685 indexed · h-index 12
Topics
Microbial Natural Products and Biosynthesis (10 papers)Bacterial Genetics and Biotechnology (4 papers)Genomics and Phylogenetic Studies (4 papers)
Partner nations
United States

In The Last Decade

Wendy Champness

13 papers receiving 675 citations

Peers

Wendy Champness
Comparison fields: 5 of 48
  • Molecular Biology 530
  • Pharmacology 519
  • Genetics 152
  • Plant Science 135
  • Biotechnology 104
Replace Claude Gerbaud with:
Claude Gerbaud France
Beatrica Ševčı́ková Slovakia
Jianqiang Huang China
Christiane Toupet Switzerland
Renáta Nováková Slovakia
D. A. Hopwood United Kingdom
Jasenka Pigac Croatia
Natalie Lomovskaya Russia
Gabe Dezeny United States
Florian Schauwecker Germany
Wendy Champness relative to Claude Gerbaud France Claude Gerbaud's profile →
Citations per field
00.5×2.6×
Claude Gerbaud · 1×
Citations per year

Countries citing papers authored by Wendy Champness

Since Specialization
Citations

This map shows the geographic impact of Wendy Champness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Champness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Champness more than expected).

Fields of papers citing papers by Wendy Champness

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Champness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Champness. The network helps show where Wendy Champness may publish in the future.

Co-authorship network of co-authors of Wendy Champness

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Champness. A scholar is included among the top collaborators of Wendy Champness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Champness. Wendy Champness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 22
2 80
3 63
4 53
5 11
6 50
7 61
8 30
9 51
10 91
11 137
12 11
13 25

About Wendy Champness

Wendy Champness is a scholar working on Pharmacology, Molecular Medicine and Molecular Biology, having authored 13 papers that have together received 685 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (10 papers), Bacterial Genetics and Biotechnology (4 papers) and Genomics and Phylogenetic Studies (4 papers). The work is most often cited by research in Pharmacology (519 citations), Biotechnology (104 citations) and Microbiology (6 citations). Wendy Champness has collaborated with scholars based in United States. Frequent co-authors include Perry J. Riggle, Paul Brian, David J. Aceti, Larry Snyder, Richard Santos, Joseph E. Peters, Tina M. Henkin and Renqiu Kong. Their work appears in journals such as Journal of Molecular Biology, Journal of Virology and Journal of Bacteriology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026